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It is an organic psychosyndrome characterized by an acute onset and 
variability, in which the main symptomatology consists of cognitive disorders, 
observed at any age. 
Delirium often occurs with acute physical illnesses. The risk of developing 
delirium increases with the initial chronic pathology of the brain, chronic 
intoxication. 
Symptomatology consists of the signs of confused consciousness and its 
decline, disorientation and disorganized thinking, inability to distinguish 
dreams and illusions from true hallucinations, confusing utterances, 
disturbances in the sleep-wake cycle, mnestic disorders, increased or 
decreased psychomotor activity. 
Delirium 
Causes of the Delirium 
Neurological causes 
• Cerebrovascular disorders: ischemic stroke, hemorrhagic stroke, 
transient ischemic attack 
• Trauma: traumatic brain injury and subdural hematoma 
• Migraine: confusional migraine, where the consciousness is altered 
• Seizure: including postictal state and nonconvulsive status epilepticus 
• Tumor: primary or metastatic brain tumor, meningeal carcinomatosis 
• Inflammation or infection: CNS vasculitis, meningitis, encephalitis, 
meningoencephalitis 
Causes of the Delirium 
Non-neurological causes 
• Endocrine disorders: Cushing syndrome, adrenal insufficiency, pituitary 
insufficiency, thyroid disorders 
• Hematologic disorders: thrombocytopenia, polycythemia, leukemic blast cell 
crisis, hyperviscosity syndrome 
• Drugs: anticholinergics, antihistamines, antiemetics, antihypertensives, 
benzodiazepines, corticosteroids, dopamine agonists, muscle relaxants, 
recreational drugs, antispasmodics, digoxin, hypnotics, opioids, sedatives, 
tricyclic antidepressants 
• Infection: sepsis, systemic infection, urinary tract infection, pneumonia, fever 
• Injury: burns, fat embolism, hypothermia, heatstroke, electrical injury 
Causes of the Delirium 
Non-neurological causes 
• Metabolic disorders: fluid and electrolyte disorders such as 
hypernatremia, hyponatremia, hypocalcemia, hypercalcemia, 
dehydration, hyperthermia, hypoglycemia, hyperosmolality, hypoxia. 
• Vascular and circulatory abnormality: cardiac arrhythmia, heart failure, 
shock, hypoperfusion states, anemia 
• Vitamin deficiency: Vitamin B12 deficiency, thiamine deficiency 
• Substance withdrawal: Withdrawal from alcohol, benzodiazepines, 
opioids, or barbiturates 
Causes of the Delirium 
 
Other causes 
• Liver failure 
• Long ICU stays 
• Sensory deprivation 
• Sleep deprivation 
• Change of environment 
• Postoperative states 
• Urinary retention 
• Mental disorders 
 
Diagnostic criteria of the Delirium 
• Disturbance in attention (reduced ability to direct, focus, sustain, and shift 
attention) and awareness. 
• Change in cognition (memory deficit, disorientation, language disturbance, 
perceptual disturbance) that is not better accounted for by a preexisting, 
established, or evolving dementia. 
• The disturbance develops over a short period (usually hours to days) and 
tends to fluctuate during the course of the day. 
• There is evidence from the history, physical examination, or laboratory 
findings that the disturbance is caused by a direct physiologic consequence 
of a general medical condition, an intoxicating substance, medication use, or 
more than one cause. 
Assessment instruments of the 
Delirium 
• Confusion Assessment Method (CAM) 
• Delirium Symptom Interview (DSI) 
• Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) 
• Intensive Care Delirium Screening Checklist (ICDSC) 
• Delirium Detection Scale (DDS)  
• Memorial Delirium Assessment Scale (MDAS) 
DD of the Delirium 
• Complete blood cell count: Infection; Anemia 
• Electrolytes : Hypo- und Hypernatremia 
• Glucose: Hypoglycemia; Diabetic ketoacidosis; Hyperosmolar nonketotic states 
• Renal and liver function tests: Liver failure; Renal  failure 
• Thyroid function test: Hypothyroidism 
• Urine analysis: Urinary tract infection 
• Microbiological tests to identify the causative agent of the Infection 
• Drug-screening 
• Magnetic resonance imaging (MRI) of the head: Strokes; Hemorrhages; Structural 
lesions 
• Lumbar punction: CNS Infection 
Prognosis 
• In patients who are admitted with delirium, mortality rates are 10-26%. 
• Patients who develop delirium during hospitalization have a mortality 
rate of 22-76% and a high rate of death during the months following 
discharge.  
• In patients who are elderly and patients in the postoperative period, 
delirium may result in a prolonged hospital stay, increased 
complications, increased cost, and long-term disability. 
Our patient 
•  Name: S. M. 
•  Sex: male 
•  Age: 84 years 
•  Location: city citizen 
•  Occupation: former school director 
Complaints 
 
• General weakness  
• Inverted perception of the world (upside 
down) but maintained right-left perception 
(all objects where they are should be) 
• Disorientation 
• Dyscoordination 
• Panic und Anxiety 
Anamnesis morbi 
• patient was delivered to the ED by ambulance, as his neighbors 
called police because they haven’t seen him around 2-3 days 
• the disease started suddenly at night when the patient was going 
to the bed after watching TV 
• these changes are followed by disorientation in space and 
coordination failure. 
• patient was conscious and understood all, but could not move, call 
someone or reach the telephone for 3 days, so he had lied on his 
floor 
• patient was oriented in time, his personality and place and he 
remembered everything 
Anamnesis vitae 
• widower since 2005 
• he lives alone and he has son 
• no known history of chronic illness; 
• hereditary diseases are not identified 
• allergic history is not burdened 
• childhood infections - no 
• sexually transmitted diseases were denied 
• smoker - no, do not abuse alcohol 
 
Objective examination 
- Conciseness - clear, state – moderate severity, body position – active, 38°С, SpO2 -96%.  
- Dental prosthesis of both jaws, swallow reflex is normal. 
- Pale skin and mucosae. Thyroid: not enlarged, soft. Peripheral lymphatic nodes – not enlarged. 
- Musculoskeletal system – no changes 
- BR – 16-17 /min 
- Lung percussion: no clinically significant changes 
- Lung auscultation: hard breathing 
- Borders of the heart: without clinically significant changes.  
- Heart auscultation: rrhythmic, heart tones – muffled, no murmurs over all points of auscultation. 
HR - 70 bts/min 
- Pulse – rrhythmic, normal, 70 bts/min. BP- 120/70 mm Hg. 
- Abdomen: normal size, symmetric, unpainful. 
- Liver: not enlarged, moderate density, no pain during palpation in right hypochondrium 
- Spleen: not palpated 
- Pasternatsky symptom – positive from both sides 
- Edemas: absent 
- Neurological status without clinically significant changes. 
Plan of survey 
• Complete blood count, urinalysis 
• Blood analysis for urogenital infections, tests for HIV, syphilis 
• Biochemical panel 
• Chest X-ray 
• ECG 
• CT-Brain + MRI Brain 
• Angiography of cerebral vessels  
• Consultations of urologist and neurologist 
 
Complete blood count 
Conclusion: leukocytosis, exicosis 
21.09.17 22.09.17 23.09.17 31.09.17 Normal range 
Hemoglobin, g/L 15,9 12,7 13,8 13,8 13,5 – 17,5 
mg/dl 
5,4 4,4 4,8 4,7 4.5-5.9 
12,5 12,7 13,1 4,7 3.5 – 8.5 
231 159 294 285 160-370 
Ht 0,45 0,37 0,40 0,43 0,40-0,53 l/l 
MCV 29,2 28,9 28,9 29,2 80-96 fl 
MCH (HbE) 35,3 33,2 34,1 33,5 28,0-33,0 pg 
MCHC 12,8 12,8 12,6 12,8 31,5-36,0 g/dl 
0,00 0,00 0,00 0,00 - 
Urine analysis 
Conclusion: UTI         
 
Options Results Normal range 
pH 6,0 5,0-7,0 
Protein, g / l Not detected to 0.033 
Glucose  Not detected absent 
Leucocytes, cells/hpf 0 6-8 
Epithelium, cells/hpf 3 ≤15-20 
Bacteria  positiv absent 
Microbiological analysis 
Urin Culture 
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Biochemical test (1) 
Conclusion: dyslipidemia 
Options 
Results Normal range 
INR 1,14 
PTT sec 30 26-36 sec 
Quick, % 80 70-120% 
LDH 280 < 250mg/dl 
HDL-Cholesterol 30 > 35 mg/dl 
LDL-Cholesterol 163 < 130 mg/dl 
LDL-HDL Ratio 5,45 < 3 
TAG 134 < 150 mg/dl 
Cholesterol  204 < 200mg/dl 
Uric acid 5,6 3,6-7,0 mg/dl 
Folic acid 11,9 3,1-20,5 µg/l 
Active Vit B12 > 256,0 > 50,0 pmol/l 
21.09.17 22.09.17 23.09.17 31.09.17 Normal range 
C-reactive protein 112,6 61,5 18,0 1,7 <5, mg/l 
Total protein (pl) 58,4 66,1 66-83,0 g/l 
Albumin  38,1 40,2-47,6 g/l 
a1-globuline 3,7 2,1-3,5 g/l 
γ-globuline 9,6 8,0-13,5 g/l 
ALT 80 54 346 60 <50 U/l 
AST - - 176 36 <50 U/l 
AP (alc.phosp) 46 173 92 40-130 U/l 
LDH 255 280 <250 U/l 
γ-GT 28 22 293 72 <60 U/l 
Total bilirubin 0,6 0,7 <1,2, mg/l 
Biochemical test (2) 
Biochemical test (3) 
21.09.17 22.09.17 23.09.17 31.09.17 Normal range 
CK 6201 4100 190 <190 U/l 
CK-MB 179 123 <25 U/l 
Troponin I 34 33 <34 ng/l 
Sodium 135 141 140 142 135-145 mmol/l 
Potassium 3,8 3,45 4,23 4,27 3,40-4,50 mmol/l 
Calcium 2,10 2,32 2,15-2,58 mmol/l 
Lipase  31 8-78 U/l 
Urea  27 18-55 mg/dl 
Creatinine, mg/dl 0,8 0,8 1,0 1,0 0,7-1,2 mg/dl 
GFR (CKD-EPI) 81 82 73 63 > 60 ml/min 
Glucose  105 74-109 mg/dl 
TSH 1,43 1,73 0,27-4,20 mU/l 
Chest X-ray 21.09.17 
 
Heart shadow is changed by 
left ventricle enlargement 
without signs of cardiac 
insufficiency. Lungs are clean 
without infiltration or 
atelectasis present. No pleural 
effusion seen, normal sinuses. 
Investigations are limited 
because of supine position of 
the patient 
 
Brain CT Scan 22.09.17 
• symmetrical ventricle disposition, 
all structures are are good 
visualized. 
• no signs of hemorrhage  
• cortex area is good visualized 
without any pathological changes  
• thalamus, gangli and cerebellum 
without pathological changes  
• mild microangiopathy but no 
hemorrhage or ischemic focuses 
• decreased brain volume 
Conclusion: no clinically important 
changes were found 
Diagnosis 
Urosepsis with Delirium and Exicosis 
Treatment  plan in the hospital 
• Ampicillin+Sulbactam 3 g IV every 8 hours during 5 days 
• Consumption of at least 2 liters of fluid per day 
• Certroparin 3000 IE s.c. 1 time per day (Thrombosis prophylaxis) 
• Melperon 5 ml per os 2-3 times per day if necessary 
 
 
Against the background of the treatment, the patient's condition 
stabilized after 3 days, 7 days after the admission the patient was 
discharged under the supervision of his family doctor.  
NCBI.gov / BioMed Central 
Sepsis-associated Delirium (SAD) 
Delirium is defined as a “transient, usually reversible cause of cerebral dysfunction and manifests clinically 
with a wide range of neuropsychiatric abnormalities” 
Treatment of urosepsis comprises four major aspects:  
• early diagnosis;  
• early goal-directed therapy including optimal pharmacodynamic exposure to antimicrobials 
both in the plasma and in the urinary tract;  
• identification and control of the complicating factor in the urinary tract; and 
• specific sepsis therapy. 
Early adequate tissue oxygenation, adequate initial antibiotic therapy, and rapid identification 
and control of the septic focus in the urinary tract are critical steps in the successful management 
of a patient with urosepsis, which includes early imaging, and an optimal interdisciplinary 
approach encompassing emergency unit, urological and intensive-care medicine specialists.  
Recommendations 
 International Journal of Urology 20(10) · May 2013 
Sedatives are often used in the intensive care unit, and the use of benzodiazepines is related to 
the increased incidence of brain dysfunction, as assessed by symptoms of delirium. 
Dexmedetomidine, an alpha-2 agonist, has been associated with less delirium than continuous 
lorazepam and midazolam in critically ill patients (the MENDS trial). Clinics (Sao Paulo). 2011 Oct; 66(10): 1825–1831. 
Conclusion 
The exact mechanism causing delirium is complex and involves the neurological 
impact arising out of the immune response causing “prolonged inflammation, brain 
cells activation, over expression of NO, dysfunction of intracellular metabolism and 
cell death”[Intensive Care Med. 2007;33:941–950]. However, to the best of our 
knowledge, only few case reports have ever noted delirium presenting as the only 
initial manifestation of urosepsis. 
The brain may be affected in sepsis, similar to any other organ, but with many unique 
effects. Therefore, efforts should be made to understand the multiple clinical 
presentations and pathophysiology of SAE to target therapies toward the mechanistic 
pathways of the disorder rather than to merely control the symptoms of SAE. 
Thank you for your attention! 
